Rocket


Overview
Financials
News + Filings
Key Docs
Ownership


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Curaleaf Holdings, Inc. (CURLF) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/10/2023 6-K Quarterly results
08/09/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Notice of Meeting and Record Date",
"Notice of Meeting",
"Notice of Abridgement",
"Management Information Circular",
"Consent and Proxy Form"
07/10/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Form 9, Notice of Issuance or Proposed Issuance of Listed Securities",
"Form 51-102F6V Statement of Executive Compensation",
"INVESTOR CONTACT",
"INVESTOR CONTACT",
"INVESTOR CONTACT",
"INVESTOR CONTACT",
"Form 7, Monthly Progress Report"
06/15/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Form 9, Notice of Issuance or Proposed Issuance of Listed Securities"
06/08/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Form 7, Monthly Progress Report"
05/18/2023 6-K Quarterly results
Docs: "6-K",
"Unaudited Condensed Interim Consolidated Financial Statements as of and for the Three Months Ended March 31, 2023 and 2022",
"Management’s Discussion and Analysis of Financial Condition and Results of Operations as of and for the Three Months Ended March 31, 2023 and 2022",
"CEO Certification of Interim Filings",
"CFO Certification of Interim Filings",
"Curaleaf Reports First Quarter 2023 Results First quarter 2023 revenue of $336.5 million, representing an increase of 14% year-over-year, and adjusted EBITDA of $73.2 million",
"Form 5, Quarterly Listing Statement"
05/05/2023 6-K Quarterly results
05/02/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Amended and Restated Unaudited Condensed Interim Consolidated Financial Statements As of and for the Three Months Ended March 31, 2022 and 2021",
"Amended and Restated Management’ s Discussion and Analysis of Financial Condition and Results of Operations As of and for the Three Months Ended March 31, 2022 and 2021",
"CEO Certification of Interim Filings",
"CFO Certification of Interim Filings",
"Amended and Restated Unaudited Condensed Interim Consolidated Financial Statements As of and for the Three and Six Months Ended June 30, 2022 and 2021",
"Amended and Restated Management’ s Discussion and Analysis of Financial Condition and Results of Operations As of and for the Three and Six Months Ended June 30, 2022 and 2021",
"CEO Certification of Interim Filings",
"CFO Certification of Interim Filings",
"Amended and Restated Unaudited Condensed Interim Consolidated Financial Statements As of and for the Three and Nine Months Ended September 30, 2022 and 2021",
"Amended and Restated Unaudited Condensed Interim Consolidated Financial Statements As of and for the Three Months Ended March 31, 2022 and 2021"
04/26/2023 6-K Quarterly results
04/24/2023 6-K Quarterly results
04/19/2023 6-K Quarterly results
04/14/2023 6-K Quarterly results
03/31/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Curaleaf Announces Acquisition of Deseret Wellness",
"Form 9, Notice of Issuance or Proposed Issuance of Listed Securities"
03/24/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"INVESTOR CONTACT"
03/22/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Form 11, Notice of Proposed Stock Option Grant or Amendment"
03/07/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Form 7, Monthly Progress Report",
"Curaleaf to Report Fourth Quarter and Fiscal Year End 2022 Financial and Operational Results"
02/21/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Notice of Change of Auditor",
"Letter of Former Auditor",
"Letter of Successor Auditor"
02/10/2023 6-K Quarterly results
01/27/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Curaleaf Announces Closure of Operations in California, Colorado and Oregon",
"INVESTOR CONTACT"
01/11/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Form 9 Notice of Issuance or Proposed Issuance of Listed Securities",
"Form 7 Monthly Progress Report",
"Form 6 Certificate of Compliance",
"Form 9 Notice of Issuance or Proposed Issuance of Listed Securities"
12/20/2022 6-K Quarterly results
11/14/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Form 9, Notice of Issuance or Proposed Issuance of Listed Securities",
"Form 6, Certificate of Compliance",
"Letter to CSE",
"Form 7, Monthly Progress Report"
11/08/2022 6-K Quarterly results
Docs: "FORM 6-K",
"Unaudited Condensed Interim Consolidated Financial Statements as of and for the Three and Nine Months Ended September 30, 2022 and 2021",
"Management’ s Discussion and Analysis of Financial Condition and Results of Operations as of and for the Three and Nine Months Ended September 30, 2022 and 2021",
"CEO Certification of Interim Filings",
"CFO Certification of Interim Filings",
"Curaleaf Reports Third Quarter 2022 Results",
"Form 5, Quarterly Listing Statement"
10/14/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Curaleaf Relocates Deerfield, IL Dispensary and Opens Doors to Adult-Use Customers"
10/07/2022 6-K Quarterly results
09/20/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Form 9, Notice of Issuance or Proposed Issuance of Listed Securities",
"Form 6, Certificate of Compliance",
"Letter to CSE",
"Curaleaf Completes Majority Stake Acquisition of Germany's Four 20 Pharma"
09/09/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Form 7 Monthly Progress Report"
09/02/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Media Contacts Curaleaf Holdings, Inc. Tracy Brady, SVP Corporation Communications [email protected] Notice regarding forward-looking statements: This media advisory contains forward–looking statements and forward–looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward–looking statements or information. Generally, forward-looking statements and information may be identified by the use of forward-looking terminology such as "plans", "expects" or, "proposed", "is expected", "intends", "anticipates", or "believes", or variations of such words and phrases, or by the use of words or phrases which state that certain actions, events or results may, ..."
08/16/2022 6-K Quarterly results
08/09/2022 6-K Quarterly results
07/11/2022 6-K Quarterly results
06/15/2022 6-K Quarterly results
05/11/2022 6-K Quarterly results
04/28/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Form 11, Notice of Proposed Issuance of Options"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy